AAAAAA
Results: 1-25/74
Authors:
ZIV I
MELAMED E
Citation: I. Ziv et E. Melamed, ROLE OF APOPTOSIS IN THE PATHOGENESIS OF PARKINSONS-DISEASE - A NOVELTHERAPEUTIC OPPORTUNITY, Movement disorders, 13(6), 1998, pp. 865-870
Authors:
DJALDETTI R
ZIV I
MELAMED E
Citation: R. Djaldetti et al., EXTREME ANTICIPATION IN YOUNG-ONSET PARKINSONS-DISEASE, Movement disorders, 13(3), 1998, pp. 599-600
Authors:
MELAMED E
OFFEN D
SHIRVAN A
DJALDETTI R
BARZILAI A
ZIV I
Citation: E. Melamed et al., LEVODOPA TOXICITY AND APOPTOSIS, Annals of neurology, 44(3), 1998, pp. 149-154
Authors:
SHIRVAN A
ZIV I
ZILKHAFALB R
MACHLYN T
BARZILAI A
MELAMED E
Citation: A. Shirvan et al., EXPRESSION OF CELL CYCLE-RELATED GENES DURING NEURONAL APOPTOSIS - ISTHERE A DISTINCT PATTERN, Neurochemical research, 23(5), 1998, pp. 767-777
PARKINSON PSYCHOSIS RATING-SCALE - A PRACTICAL INSTRUMENT FOR GRADINGPSYCHOSIS IN PARKINSONS-DISEASE
Authors:
FRIEDBERG G
ZOLDAN J
WEIZMAN A
MELAMED E
Citation: G. Friedberg et al., PARKINSON PSYCHOSIS RATING-SCALE - A PRACTICAL INSTRUMENT FOR GRADINGPSYCHOSIS IN PARKINSONS-DISEASE, Clinical neuropharmacology, 21(5), 1998, pp. 280-284
Authors:
ZIV I
DJALDETTI R
ZOLDAN Y
AVRAHAM M
MELAMED E
Citation: I. Ziv et al., DIAGNOSIS OF NONORGANIC LIMB PARESIS BY A NOVEL OBJECTIVE MOTOR-ASSESSMENT - THE QUANTITATIVE HOOVERS TEST, Journal of neurology, 245(12), 1998, pp. 797-802
Authors:
OFFEN D
HALEVI S
ORION D
MOSBERG R
STERNGOLDBERG H
MELAMED E
ATLAS D
Citation: D. Offen et al., ANTIBODIES FROM ALS PATIENTS INHIBIT DOPAMINE RELEASE MEDIATED BY L-TYPE CALCIUM CHANNELS, Neurology, 51(4), 1998, pp. 1100-1103
Authors:
DJALDETTI R
MELAMED E
Citation: R. Djaldetti et E. Melamed, MANAGEMENT OF RESPONSE FLUCTUATIONS - PRACTICAL GUIDELINES, Neurology, 51(2), 1998, pp. 36-40
Authors:
ZIV I
SHIRVAN A
BARZILAI A
FLEMINGER G
MELAMED E
Citation: I. Ziv et al., PROTECTIVE EFFECT OF ANTI-COLLAPSIN-1 ANTIBODY AGAINST DOPAMINE AND MPP- POSSIBLE IMPLICATIONS FOR NEURODEGENERATIVE DISORDERS( TOXICITY INPOSTMITOTIC NEURONS ), Neurology, 50(4), 1998, pp. 2106-2106
Authors:
OFFEN D
BEART PM
CHEUNG NS
PASCOE CJ
HOCHMAN A
GORODIN S
MELAMED E
BERNARD R
BERNARD O
Citation: D. Offen et al., TRANSGENIC MICE EXPRESSING HUMAN BCL-2 IN THEIR NEURONS ARE RESISTANTTO 6-HYDROXYDOPAMINE AND 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINENEUROTOXICITY, Proceedings of the National Academy of Sciences of the United Statesof America, 95(10), 1998, pp. 5789-5794
Authors:
HOCHMAN A
STERNIN H
GORODIN S
KORSMEYER S
ZIV I
MELAMED E
OFFEN D
Citation: A. Hochman et al., ENHANCED OXIDATIVE STRESS AND ALTERED ANTIOXIDANTS IN BRAINS OF BCL-2-DEFICIENT MICE, Journal of neurochemistry, 71(2), 1998, pp. 741-748
Authors:
ZIV I
OFFEN D
HAVIV R
STEIN R
PANET H
ZILKHAFALB R
SHIRVAN A
BARZILAI A
MELAMED E
Citation: I. Ziv et al., THE PROTOONCOGENE BCL-2 INHIBITS CELLULAR TOXICITY OF DOPAMINE - POSSIBLE IMPLICATIONS FOR PARKINSONS-DISEASE, Apoptosis, 2(2), 1997, pp. 149-155
Authors:
SHIRVAN A
BARZILAI A
ZIV I
FLEMINGER G
MACHLIN T
BRUDO I
MELAMED E
Citation: A. Shirvan et al., INDUCTION OF COLLAPSIN AND COLLAPSIN RESPONSIVE MEDIATOR IS COUPLED TO NEURONAL APOPTOSIS AND MEDIATE CELL-DEATH, Molecular biology of the cell, 8, 1997, pp. 709-709
Authors:
MELAMED LE
MELAMED E
Citation: Le. Melamed et E. Melamed, CASE-STUDY - A LONGITUDINAL EVALUATION OF NEUROPSYCHOLOGICAL FUNCTIONING AND ASSOCIATED BEHAVIORS IN A HIGH-FUNCTIONING AUTISTIC-CHILD, Archives of clinical neuropsychology, 12(4), 1997, pp. 369-369
Authors:
ZIV I
ZILKHAFALB R
OFFEN D
SHIRVAN A
BARZILAI A
MELAMED E
Citation: I. Ziv et al., LEVODOPA INDUCES APOPTOSIS IN CULTURED NEURONAL CELLS - A POSSIBLE ACCELERATOR OF NIGROSTRIATAL DEGENERATION IN PARKINSONS-DISEASE, Movement disorders, 12(1), 1997, pp. 17-23
Authors:
OFFEN D
BEART P
CHOUNG S
PASCOE C
HOCHMAN A
GORODIN S
MELAMED E
BERNARD R
BERNARD O
Citation: D. Offen et al., TRANSGENIC MICE EXPRESSING HUMAN BCL-2 IN THEIR NEURONS ARE RESISTANTTO NEUROTOXICITY OF 6-OH-DOPAMINE AND MPTP, Neuroscience letters, 1997, pp. 38-38
Authors:
ZILKHAFALB R
SHIRVAN A
DJALDETI R
ZIV I
MACHLIN T
MELAMED E
BARZILAI A
Citation: R. Zilkhafalb et al., INDUCTION OF T-COMPLEX PROTEIN-1 (TCP-1) EXPRESSION DURING DOPAMINE-TRIGGERED NEURONAL APOPTOSIS IN CHICK-EMBRYO SYMPATHETIC NEURONS, Neuroscience letters, 1997, pp. 55-55
Authors:
SHIRVAN A
ZIV I
BARZILAI A
DJALDETI R
ZILKHFALB R
MICHLIN T
MELAMED E
Citation: A. Shirvan et al., INDUCTION OF MITOSIS-RELATED GENES DURING DOPAMINE-TRIGGERED APOPTOSIS IN SYMPATHETIC NEURONS, Journal of neural transmission. Supplementum, (50), 1997, pp. 67-78
Authors:
ZIV I
BARZILAI A
OFFEN D
NARDI N
MELAMED E
Citation: I. Ziv et al., NIGROSTRIATAL NEURONAL DEATH IN PARKINSONS-DISEASE - A PASSIVE OR AN ACTIVE GENETICALLY-CONTROLLED PROCESS, Journal of neural transmission. Supplementum, (49), 1997, pp. 69-76
Authors:
ZIV I
OFFEN D
BARZILAI A
HAVIV R
STEIN R
ZILKHAFALB R
SHIRVAN A
MELAMED E
Citation: I. Ziv et al., MODULATION OF CONTROL MECHANISMS OF DOPAMINE-INDUCED APOPTOSIS - A FUTURE APPROACH TO THE TREATMENT OF PARKINSONS-DISEASE, Journal of neural transmission. Supplementum, (49), 1997, pp. 195-202
Authors:
OFFEN D
ZIV I
PANET H
WASSERMAN L
STEIN R
MELAMED E
BARZILAI A
Citation: D. Offen et al., DOPAMINE-INDUCED APOPTOSIS IS INHIBITED IN PC12 CELLS EXPRESSING BCL-2, Cellular and molecular neurobiology, 17(3), 1997, pp. 289-304
Authors:
ZILKHAFALB R
ZIV I
NARDI N
OFFEN D
MELAMED E
BARZILAI A
Citation: R. Zilkhafalb et al., MONOAMINE-INDUCED APOPTOTIC NEURONAL CELL-DEATH, Cellular and molecular neurobiology, 17(1), 1997, pp. 101-118
Authors:
OFFEN D
ZIV I
BARZILAI A
GORODIN S
GLATER E
HOCHMAN A
MELAMED E
Citation: D. Offen et al., DOPAMINE-MELANIN INDUCES APOPTOSIS IN PC12 CELLS - POSSIBLE IMPLICATIONS FOR THE ETIOLOGY OF PARKINSONS-DISEASE, Neurochemistry international, 31(2), 1997, pp. 207-216
Authors:
SHANKMAN S
BELTRAN J
MELAMED E
ROSENBERG ZS
Citation: S. Shankman et al., ANTERIOR HORN OF THE LATERAL MENISCUS - ANOTHER POTENTIAL PITFALL IN MR-IMAGING OF THE KNEEL, Radiology, 204(1), 1997, pp. 181-184
Authors:
DJALDETTI R
ROSMARIN V
ZIV I
MELAMED E
Citation: R. Djaldetti et al., THE PHARMACOKINETIC PROFILE OF THE FIRST EVER ORAL DOSE OF LEVODOPA IN DE-NOVO PATIENTS WITH PARKINSONS-DISEASE, Neurology, 48(3), 1997, pp. 3099-3099